Tini Garske
Overview
Explore the profile of Tini Garske including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
2668
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Echeverria-Londono S, Li X, Toor J, de Villiers M, Nayagam S, Hallett T, et al.
BMC Public Health
. 2021 Nov;
21(1):2049.
PMID: 34753437
Background: Deaths due to vaccine preventable diseases cause a notable proportion of mortality worldwide. To quantify the importance of vaccination, it is necessary to estimate the burden averted through vaccination....
2.
Hamlet A, Ramos D, Gaythorpe K, Romano A, Garske T, Ferguson N
Nat Commun
. 2021 Jun;
12(1):3647.
PMID: 34131128
Yellow fever virus (YFV) is a zoonotic arbovirus affecting both humans and non-human primates (NHP's) in Africa and South America. Previous descriptions of YF's seasonality have relied purely on climatic...
3.
Gaythorpe K, Hamlet A, Jean K, Ramos D, Cibrelus L, Garske T, et al.
Elife
. 2021 Mar;
10.
PMID: 33722340
Yellow fever (YF) is a viral, vector-borne, haemorrhagic fever endemic in tropical regions of Africa and South America. The vaccine for YF is considered safe and effective, but intervention strategies...
4.
Jean K, Raad H, Gaythorpe K, Hamlet A, Mueller J, Hogan D, et al.
PLoS Med
. 2021 Feb;
18(2):e1003523.
PMID: 33600451
Background: The Eliminate Yellow fever Epidemics (EYE) strategy was launched in 2017 in response to the resurgence of yellow fever in Africa and the Americas. The strategy relies on several...
5.
Li X, Mukandavire C, Cucunuba Z, Echeverria Londono S, Abbas K, Clapham H, et al.
Lancet
. 2021 Jan;
397(10272):398-408.
PMID: 33516338
Background: The past two decades have seen expansion of childhood vaccination programmes in low-income and middle-income countries (LMICs). We quantify the health impact of these programmes by estimating the deaths...
6.
Hamlet A, Gaythorpe K, Garske T, Ferguson N
PLoS Negl Trop Dis
. 2021 Jan;
15(1):e0008974.
PMID: 33428623
In the last 20 years yellow fever (YF) has seen dramatic changes to its incidence and geographic extent, with the largest outbreaks in South America since 1940 occurring in the...
7.
Gaythorpe K, Hamlet A, Cibrelus L, Garske T, Ferguson N
Elife
. 2020 Jul;
9.
PMID: 32718436
Yellow Fever (YF) is an arbovirus endemic in tropical regions of South America and Africa and it is estimated to cause 78,000 deaths a year in Africa alone. Climate change...
8.
Jean K, Hamlet A, Benzler J, Cibrelus L, Gaythorpe K, Sall A, et al.
PLoS Negl Trop Dis
. 2020 May;
14(5):e0008304.
PMID: 32379756
Background: To counter the increasing global risk of Yellow fever (YF), the World Health Organisation initiated the Eliminate Yellow fever Epidemics (EYE) strategy. Estimating YF burden, as well as vaccine...
9.
Dorigatti I, Morrison S, Donnelly C, Garske T, Bowden S, Grills A
Sci Rep
. 2020 Jan;
9(1):20420.
PMID: 31892703
Southeast Brazil has experienced two large yellow fever (YF) outbreaks since 2016. While the 2016-2017 outbreak mainly affected the states of Espírito Santo and Minas Gerais, the 2017-2018 YF outbreak...
10.
Gaythorpe K, Jean K, Cibrelus L, Garske T
PLoS Comput Biol
. 2019 Sep;
15(9):e1007355.
PMID: 31545790
Yellow fever is a vector-borne disease endemic in tropical regions of Africa, where 90% of the global burden occurs, and Latin America. It is notoriously under-reported with uncertainty arising from...